Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: Prevalence and clinical correlates

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Becker, Anthony C ^a   Libhaber, Elena ^a   Sliwa, Karen ^a   Singh, Sham ^c   Stewart, Simon ^b   Tikly, Mohammed ^a   Essop, Mohammed R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c LANCET LABORATORIES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80053535552     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-379     Document Type: Article

References (18)

1. HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. Hassoun A, Al-Kadhimi Z, Cervia J, AIDS Patient Care STDS 2004 18 6 333 40 (Pubitemid 38821789)
2. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Abuaf N, Thromb Haemost 1997 77 856 61 (Pubitemid 27239104)
3. Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Loizou S, Singh S, Wypkema E, Asherson RA, Ann Rheum Dis 2003 62 11 1106 11 (Pubitemid 37323577)
4. Arterial thrombosis and the role of thrombophilia. Boekholdt SM, Kramer MH, Semin Thromb Hemost 2007 33 6 588 96 (Pubitemid 47429311)
5. Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study. Zuckerman E, Toubi E, Shiran A, Sabo E, Shmuel Z, Golan TD, et al. Am J Med 1996 101 4 381 6 (Pubitemid 26392855)
6. Acute Coronary Syndromes in Treatment-Naive Black South Africans with Human Immunodeficiency Virus Infection. Becker AC, Sliwa K, Stewart S, Libhaber E, Essop AR, Zambakides CA, Essop MR, Journal of Interventional Cardiology 2010 23 1 70 77
7. The Thrombotic Profile of Treatment-Nave HIV Positive Black South Africans with Acute Coronary Syndromes. Becker AC, Jacobson B, Singh S, Sliwa K, Stewart S, Libhaber E, Essop MR, Clinical and Applied Thrombosis/Hemostasis 2010
8. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Yusuf S, Lancet 2004 364 937 52
9. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. CDC, 1993
10. Management of acute myocardial infarction in patients presenting with ST-segment elevation. task Force of the ESC. Van der Werf F, European Heart Journal 2003 24 28 66
11. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, et al. Eur Heart J 2002 23 23 1809 40
12. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Miyakis S LMD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. Journal of Thrombosis and Haemostasis 2006 4 295 306
13. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Abuaf N, Laperche S, Rajoely B, Carsique R, Deschamps A, Rouquette AM, et al. Thromb Haemost 1997 77 5 856 61 (Pubitemid 27239104)
14. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, et al. Circulation 2004 109 3 316 9 (Pubitemid 38133896)
15. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM, J Autoimmun 1999 13 3 347 55
16. Transitory anti-beta2-glycoprotein I antibodies in infections. Guerin V, Ryman A, Couchouron A, Lupus 1999 8 6 490 1
17. Antibodies to beta2-glycoprotein I - a specific marker for the antiphospholipid syndrome. Guerin J, Feighery C, Sim RB, Jackson J, Clin Exp Immunol 1997 109 2 304 9 (Pubitemid 27308418)
18. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Lancet 2007 370 9596 1453 7